On 1 February 2016
Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 1 February 2016 to consider and approve Unaudited Financial Results of the Company for the third quarter and nine months ended 31 December, 2015(Q3).Powered by Capital Market - Live News